Amgen Eyes Deals, International Expansion; Looking to Enter 75 New Markets Over Next 5 Years

NEW YORK, Sept 22 (Reuters) - Amgen Inc (AMGN.O) is aggressively eyeing global expansion and looking at acquisition opportunities and drug licensing deals that can help the world's largest biotechnology company to achieve that goal.